WEZLANA ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial (2023-24)
Product name
WEZLANA ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial
Sponsor name
Amgen Australia Pty Ltd
Year Range
2023-24